Topography-biased compound library design: the shape of things to come?

The design and synthesis of quality compound libraries is of critical importance to any pharmaceutical company that relies on high throughput screening efforts for the identification of lead compounds. In this perspective, we use a moment of inertia derived shape analysis to interrogate potential li...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug discovery today 2007-11, Vol.12 (21), p.948-952
Hauptverfasser: Akritopoulou-Zanze, Irini, Metz, James T., Djuric, Stevan W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 952
container_issue 21
container_start_page 948
container_title Drug discovery today
container_volume 12
creator Akritopoulou-Zanze, Irini
Metz, James T.
Djuric, Stevan W.
description The design and synthesis of quality compound libraries is of critical importance to any pharmaceutical company that relies on high throughput screening efforts for the identification of lead compounds. In this perspective, we use a moment of inertia derived shape analysis to interrogate potential libraries for chemical synthesis. An analysis of known ‘Rule of Five’ compliant drug shapes using this methodology clearly highlights compound libraries that may be reasonably expected, shape wise, to interact with biologically relevant protein active site topography and those that, although being structurally diverse in shape, have little chance of being pharmacologically productive. The use of multicomponent reactions as a means of producing structurally novel, bioactive compounds in a synthetically expeditious manner is also highlighted.
doi_str_mv 10.1016/j.drudis.2007.08.017
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68501107</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1359644607003704</els_id><sourcerecordid>20772441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-5f64ffcfac372d112b71f4285dd190e4f59dba9f7dd1c5fbb49c061b079b77243</originalsourceid><addsrcrecordid>eNqFkU2LFDEQhoMo7u7oPxDpk7duU-l8dDwosrirsOBlPYdOUpnJMNNpk25h_70ZZsCbe6oqeKoK3oeQd0A7oCA_7jufVx9LxyhVHR06CuoFuYZBDa0Yevay9r3QreRcXpGbUvaUAtNCviZXoLTuOfTX5P4xzWmbx3n31No4FvSNS8c5rZNvDtHmMT81HkvcTp-aZYdN2Y0zNinUIU7b0izpxOOXN-RVGA8F317qhvy6-_Z4-719-Hn_4_brQ-s4Y0srguQhuDC6XjEPwKyCwNkgvAdNkQehvR11UHV2IljLtaMSLFXaKsV4vyEfznfnnH6vWBZzjMXh4TBOmNZi5CAoAFXPgj1IwSQXz4KMnh7XsDaEn0GXUykZg5lzPNaADFBzUmL25qzEnJQYOpiqpK69v9xf7RH9v6WLgwp8PgNYc_sTMZviIk4OfczoFuNT_P-Hv3ZNnqY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20772441</pqid></control><display><type>article</type><title>Topography-biased compound library design: the shape of things to come?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Akritopoulou-Zanze, Irini ; Metz, James T. ; Djuric, Stevan W.</creator><creatorcontrib>Akritopoulou-Zanze, Irini ; Metz, James T. ; Djuric, Stevan W.</creatorcontrib><description>The design and synthesis of quality compound libraries is of critical importance to any pharmaceutical company that relies on high throughput screening efforts for the identification of lead compounds. In this perspective, we use a moment of inertia derived shape analysis to interrogate potential libraries for chemical synthesis. An analysis of known ‘Rule of Five’ compliant drug shapes using this methodology clearly highlights compound libraries that may be reasonably expected, shape wise, to interact with biologically relevant protein active site topography and those that, although being structurally diverse in shape, have little chance of being pharmacologically productive. The use of multicomponent reactions as a means of producing structurally novel, bioactive compounds in a synthetically expeditious manner is also highlighted.</description><identifier>ISSN: 1359-6446</identifier><identifier>EISSN: 1878-5832</identifier><identifier>DOI: 10.1016/j.drudis.2007.08.017</identifier><identifier>PMID: 17993413</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Chemistry, Pharmaceutical ; Drug Design ; Molecular Conformation</subject><ispartof>Drug discovery today, 2007-11, Vol.12 (21), p.948-952</ispartof><rights>2007 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-5f64ffcfac372d112b71f4285dd190e4f59dba9f7dd1c5fbb49c061b079b77243</citedby><cites>FETCH-LOGICAL-c422t-5f64ffcfac372d112b71f4285dd190e4f59dba9f7dd1c5fbb49c061b079b77243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.drudis.2007.08.017$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17993413$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Akritopoulou-Zanze, Irini</creatorcontrib><creatorcontrib>Metz, James T.</creatorcontrib><creatorcontrib>Djuric, Stevan W.</creatorcontrib><title>Topography-biased compound library design: the shape of things to come?</title><title>Drug discovery today</title><addtitle>Drug Discov Today</addtitle><description>The design and synthesis of quality compound libraries is of critical importance to any pharmaceutical company that relies on high throughput screening efforts for the identification of lead compounds. In this perspective, we use a moment of inertia derived shape analysis to interrogate potential libraries for chemical synthesis. An analysis of known ‘Rule of Five’ compliant drug shapes using this methodology clearly highlights compound libraries that may be reasonably expected, shape wise, to interact with biologically relevant protein active site topography and those that, although being structurally diverse in shape, have little chance of being pharmacologically productive. The use of multicomponent reactions as a means of producing structurally novel, bioactive compounds in a synthetically expeditious manner is also highlighted.</description><subject>Chemistry, Pharmaceutical</subject><subject>Drug Design</subject><subject>Molecular Conformation</subject><issn>1359-6446</issn><issn>1878-5832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU2LFDEQhoMo7u7oPxDpk7duU-l8dDwosrirsOBlPYdOUpnJMNNpk25h_70ZZsCbe6oqeKoK3oeQd0A7oCA_7jufVx9LxyhVHR06CuoFuYZBDa0Yevay9r3QreRcXpGbUvaUAtNCviZXoLTuOfTX5P4xzWmbx3n31No4FvSNS8c5rZNvDtHmMT81HkvcTp-aZYdN2Y0zNinUIU7b0izpxOOXN-RVGA8F317qhvy6-_Z4-719-Hn_4_brQ-s4Y0srguQhuDC6XjEPwKyCwNkgvAdNkQehvR11UHV2IljLtaMSLFXaKsV4vyEfznfnnH6vWBZzjMXh4TBOmNZi5CAoAFXPgj1IwSQXz4KMnh7XsDaEn0GXUykZg5lzPNaADFBzUmL25qzEnJQYOpiqpK69v9xf7RH9v6WLgwp8PgNYc_sTMZviIk4OfczoFuNT_P-Hv3ZNnqY</recordid><startdate>20071101</startdate><enddate>20071101</enddate><creator>Akritopoulou-Zanze, Irini</creator><creator>Metz, James T.</creator><creator>Djuric, Stevan W.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7U5</scope><scope>L7M</scope><scope>7X8</scope></search><sort><creationdate>20071101</creationdate><title>Topography-biased compound library design: the shape of things to come?</title><author>Akritopoulou-Zanze, Irini ; Metz, James T. ; Djuric, Stevan W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-5f64ffcfac372d112b71f4285dd190e4f59dba9f7dd1c5fbb49c061b079b77243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Chemistry, Pharmaceutical</topic><topic>Drug Design</topic><topic>Molecular Conformation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akritopoulou-Zanze, Irini</creatorcontrib><creatorcontrib>Metz, James T.</creatorcontrib><creatorcontrib>Djuric, Stevan W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>MEDLINE - Academic</collection><jtitle>Drug discovery today</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akritopoulou-Zanze, Irini</au><au>Metz, James T.</au><au>Djuric, Stevan W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Topography-biased compound library design: the shape of things to come?</atitle><jtitle>Drug discovery today</jtitle><addtitle>Drug Discov Today</addtitle><date>2007-11-01</date><risdate>2007</risdate><volume>12</volume><issue>21</issue><spage>948</spage><epage>952</epage><pages>948-952</pages><issn>1359-6446</issn><eissn>1878-5832</eissn><abstract>The design and synthesis of quality compound libraries is of critical importance to any pharmaceutical company that relies on high throughput screening efforts for the identification of lead compounds. In this perspective, we use a moment of inertia derived shape analysis to interrogate potential libraries for chemical synthesis. An analysis of known ‘Rule of Five’ compliant drug shapes using this methodology clearly highlights compound libraries that may be reasonably expected, shape wise, to interact with biologically relevant protein active site topography and those that, although being structurally diverse in shape, have little chance of being pharmacologically productive. The use of multicomponent reactions as a means of producing structurally novel, bioactive compounds in a synthetically expeditious manner is also highlighted.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>17993413</pmid><doi>10.1016/j.drudis.2007.08.017</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1359-6446
ispartof Drug discovery today, 2007-11, Vol.12 (21), p.948-952
issn 1359-6446
1878-5832
language eng
recordid cdi_proquest_miscellaneous_68501107
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Chemistry, Pharmaceutical
Drug Design
Molecular Conformation
title Topography-biased compound library design: the shape of things to come?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T18%3A08%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Topography-biased%20compound%20library%20design:%20the%20shape%20of%20things%20to%20come?&rft.jtitle=Drug%20discovery%20today&rft.au=Akritopoulou-Zanze,%20Irini&rft.date=2007-11-01&rft.volume=12&rft.issue=21&rft.spage=948&rft.epage=952&rft.pages=948-952&rft.issn=1359-6446&rft.eissn=1878-5832&rft_id=info:doi/10.1016/j.drudis.2007.08.017&rft_dat=%3Cproquest_cross%3E20772441%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20772441&rft_id=info:pmid/17993413&rft_els_id=S1359644607003704&rfr_iscdi=true